Johnson & Johnson (JNJ) research: valuation against peers, fundamentals over time, risk and news coverage
JNJ
Johnson & JohnsonNo data in this window.
Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.
- BREAKING STORYBEARISHCiena Slides Nearly 9% as Analyst Trims Target, CFO Sells $2.15 Million in Stock
Ciena shares fell almost 9% after an analyst reduced his price target on the optical networking supplier, a move compounded by disclosure that CFO Marc Graff sold $2.15 million in company stock. The session formed part of a wider pattern of heavy insider selling across mid-cap issuers.
Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.
Only 1 resolved forecast on record — below the 6-period threshold, so no verdict is published.
n = 1 resolved forecast · FY 2024 to FY 2024 · 7 still outstanding
Insufficient sample — no verdict published. JNJ has 1 resolved forecast on record, below the 6 needed before we will characterise a management team’s forecasting. The record below is published in full; the company is excluded from every ranking on this site until it clears the threshold.
Next report expected 13 Oct 2026 (Q3 FY2026) — Estimated from the issuer's own filing history: FY2025Q3 results were released on 2025-10-14. source
| Period | Measure | Guided | Issued | Reported | Landed | Deviation | Verdict | Sources |
|---|---|---|---|---|---|---|---|---|
| FY 2026revised | EPS (adj.) | $11.68 | 2026-07-15 | — | — | — | PENDING | guidance |
| “increasing adjusted EPS* guidance by $0.13 to $11.68 or 8.2% at the midpoint” | ||||||||
| FY 2026revised | Revenue | $101.1bn | 2026-07-15 | — | — | — | PENDING | guidance |
| “Strong operational performance results in the Company increasing 2026 guidance with estimated reported sales of $101.1 Billion or 7.3% at the midpoint” | ||||||||
| FY 2026revised | EPS (adj.) | $11.55 | 2026-04-14 | — | — | — | PENDING | guidance |
| “Company increases 2026 guidance with estimated reported sales of $100.8 Billion or 7.0% at the midpoint, and adjusted EPS4 of $11.55 or 7.1% at the midpoint” | ||||||||
| FY 2026revised | Revenue | $100.8bn | 2026-04-14 | — | — | — | PENDING | guidance |
| “Company increases 2026 guidance with estimated reported sales of $100.8 Billion or 7.0% at the midpoint, and adjusted EPS4 of $11.55 or 7.1% at the midpoint” | ||||||||
| FY 2026 | EPS (adj.) | $11.53 | 2026-01-21 | — | — | — | PENDING | guidance |
| “Company issues guidance for 2026 with estimated reported sales of $100.5 Billion or 6.7% at the midpoint, and adjusted EPS4 of $11.53 or 6.9% at the midpoint” | ||||||||
| FY 2026 | Revenue | $100.5bn | 2026-01-21 | — | — | — | PENDING | guidance |
| “Company issues guidance for 2026 with estimated reported sales of $100.5 Billion or 6.7% at the midpoint, and adjusted EPS4 of $11.53 or 6.9% at the midpoint” | ||||||||
| FY 2025revised | EPS (adj.) | $10.85 | 2025-10-14 | — | — | — | PENDING | guidance |
| “Company increases full year estimated reported sales5 guidance to $93.7B or 5.7% at the midpoint; reaffirms full year adjusted EPS4 guidance of $10.85 at the midpoint, absorbing higher tax costs” | ||||||||
| FY 2025 | Revenue | $93.7bn | 2025-10-14 | — | — | — | PENDING | guidance |
| “Company increases full year estimated reported sales5 guidance to $93.7B or 5.7% at the midpoint; reaffirms full year adjusted EPS4 guidance of $10.85 at the midpoint, absorbing higher tax costs” | ||||||||
| FY 2025 | EPS (adj.) | $10.75–$10.95 | 2025-01-22 | — | — | — | PENDING | guidance |
| “Company issues guidance for 2025 with operational sales5 growth of 2.5% - 3.5%* and adjusted operational EPS of $10.75 - $10.95, reflecting strong growth of 8.7%* at the mid-point” | ||||||||
| FY 2024revised | EPS (adj.) | $9.91 | 2024-10-15 | $9.98 | 0.0% | IN LINE | guidance · result | |
| “October 2024 Adjusted Operational EPS1,2 $9.91” | ||||||||
| FY 2024revised | Revenue (adj.) | $89.40–$89.80bn | 2024-10-15 | — | — | — | PENDING | guidance |
| “Operational Sales2,5/ Mid-point $89.4B – $89.8B / $89.6B” | ||||||||
| FY 2024revised | EPS (adj.) | $10.05 | 2024-07-17 | $9.98 | 0.0% | IN LINE | guidance · result | |
| “July 2024 Adjusted Operational EPS1,2 $10.05” | ||||||||
| FY 2024 | Revenue (adj.) | $89.20–$89.60bn | 2024-07-17 | — | — | — | PENDING | guidance |
| “Operational Sales2,5/ Mid-point Change vs. Prior Year / Mid-point $89.2B – $89.6B / $89.4B 6.1% – 6.6% / 6.4%” | ||||||||
| FY 2024 | EPS (adj.) | $10.55–$10.75 | 2024-01-23 | $9.98 | −5.4% | BELOW | guidance · result | |
| “Company re-confirms guidance for 2024 with operational sales5 growth of 5.0% - 6.0%* and adjusted operational EPS of $10.55 - $10.75, reflecting growth of 7.4%* at the mid-point” | ||||||||
| FY 2023 | EPS (adj.) | $10.00–$10.10 | 2023-08-30 | — | — | — | PENDING | guidance |
| “Company expects 2023 Adjusted Reported Earnings Per Share (EPS) of $10.00 - $10.10, reflecting increased growth of 12.5% at the mid-point” | ||||||||
| FY 2023 | Revenue (adj.) | $83.60–$84.40bn | 2023-08-30 | — | — | — | PENDING | guidance |
| “Operational Sales2,5 / Mid-point Change vs. Prior Year / Mid-point $83.6B – $84.4B / $84.0B 7.5% – 8.5% / 8.0%” | ||||||||
Every figure above is read from the company’s own filings. “Guidance” links to the 8-K exhibit that issued the forecast; “result” links to the exhibit in which the company reported the outcome. Nothing here is an analyst estimate. How this is measured.